Delivery Order SPE2DB22D3501-SPE2DB25FWB84

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,449.31 firm fixed-price delivery order is for the supply of SPRAVATO 56 MG DOSE PACK medical products. The contract has an ultimate completion date of April 11, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SPRAVATO 84 MG DOSE PACK UDS. The contract has a ceiling value of $7,272.62 and a completion date of June 16, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPRAVATO 84 MG DOSE PACK UDS. The contract has a firm fixed price of $8,057.79 and an ultimate completion date of July 30, 2024. The contract is not designated as a set-aside award. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product. The contract has a firm fixed price of $8,466.28 and a completion date of April 30, 2025. This contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a medical product, with a ceiling value of $8,812.72. The contract is a firm-fixed price delivery order with a completion date of June 9, 2025. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the Defense Logistics Agency (DLA) with Spravato 84 mg dose packs. The $2,999.45 firm fixed price contract has a period of performance through May 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is part of Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $15,328.09 firm fixed-price delivery order is for the supply of SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product, with a period of performance through February 22, 2024. The award was not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of SPRAVATO 84 MG DOSE PACK UDS pharmaceutical products. The contract, valued at $22,963.32, has an ultimate completion date of August 30, 2024 and was awarded on August 29, 2024. The contract is a Delivery Order placed by the Medical Supply Chain, a part of the Defense Logistics Agency (DLA). This contract does not have a set-aside designation. Amerisourcebergen, as a major...
This federal contract award, valued at $13,927.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, is for the provision of SPRAVATO 84 MG DOSE PACK UDS, a specialty medication. The contract has no set-aside designation, indicating open competition. This IDC, valued at $999,999,999 and...
This federal contract award, with an ID of SPE2DX15D1022|SPE2DX25FVDFJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $25,384.32 firm fixed-price delivery order is for the supply of SPRAVATO 84 MG DOSE PACK UDS medical products. The contract has a period of performance through March 18, 2025 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FWB84
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,897.98, is for the supply of SPRAVATO 56 MG DOSE PACK UDS, a prescription medication. The contract has an ultimate completion date of June 18, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization based in Conshohocken, Pennsylvania, and is registered in the System for Award Management (SAM.gov) through May 27, 2026.

Generated 9/16/25, 9:53 AM